Clinical Trials Browser

Phase 1 × Breast Neoplasms × Immunotherapy × Clear all

NCT06130826 2025-05-30

Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer

Phase 1 Recruiting

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms